Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors
- 31 January 2008
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 198 (1), 124.e1-124.e7
- https://doi.org/10.1016/j.ajog.2007.06.079
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Soluble Endoglin and Other Circulating Antiangiogenic Factors in PreeclampsiaThe New England Journal of Medicine, 2006
- Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal bloodJournal of Medical Genetics, 2006
- Circulating Angiogenic Factors in the Pathogenesis and Prediction of PreeclampsiaHypertension, 2005
- A Role for Endoglin in Coupling eNOS Activity and Regulating Vascular Tone Revealed in Hereditary Hemorrhagic TelangiectasiaCirculation Research, 2005
- Angiogenin and vascular endothelial growth factor in pregnancies complicated by preeclampsiaInternational Journal of Gynecology & Obstetrics, 2004
- Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia developAmerican Journal of Obstetrics and Gynecology, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaThe New England Journal of Medicine, 2004
- Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patientsPrenatal Diagnosis, 2004
- Proteinuria and Hypertension Are Independent Factors Affecting Fetal DNA Values: A Retrospective Analysis of Affected and Unaffected PatientsClinical Chemistry, 2004
- A murine model of hereditary hemorrhagic telangiectasiaJCI Insight, 1999